Single-cell RNA sequencing identifies interferon-inducible monocytes/macrophages as a cellular target for mitigating the progression of abdominal aortic aneurysm and rupture risk

Cardiovasc Res. 2024 Sep 21;120(11):1351-1364. doi: 10.1093/cvr/cvae117.

Abstract

Aims: Abdominal aortic aneurysm (AAA) represents a life-threatening condition characterized by medial layer degeneration of the abdominal aorta. Nevertheless, knowledge regarding changes in regulators associated with aortic status remains incomplete. A thorough understanding of cell types and signalling pathways involved in the development and progression of AAAs is essential for the development of medical therapy.

Methods and results: We harvested specimens of the abdominal aorta with different pathological features in Angiotensin II (AngII)-infused ApoE-/- mice, conducted scRNA-seq, and identified a unique population of interferon-inducible monocytes/macrophages (IFNICs), which were amply found in the AAAs. Gene set variation analysis revealed that activation of the cytosolic DNA sensing cGAS-STING and JAK-STAT pathways promoted the secretion of type I interferons in monocytes/macrophages and differentiated them into IFNICs. We generated myeloid cell-specific deletion of Sting1 (Lyz2-Cre+/-; Sting1flox/flox) mice and performed bone marrow transplantation and found that myeloid cell-specific deletion of Sting1 or Ifnar1 significantly reduced the incidence of AAA, aortic rupture rate, and diameter of the abdominal aorta. Mechanistically, the activated pyroptosis- and inflammation-related signalling pathways, regulated by IRF7 in IFNICs, play critical roles in the developing AAAs.

Conclusion: IFNICs are a unique monocyte/macrophage subset implicated in the development of AAAs and aortic rupture.

Keywords: Abdominal aortic aneurysm; IFNICs; Inflammation; Intramural haematoma; ScRNA-sequencing.

MeSH terms

  • Angiotensin II*
  • Animals
  • Aorta, Abdominal* / immunology
  • Aorta, Abdominal* / metabolism
  • Aorta, Abdominal* / pathology
  • Aortic Aneurysm, Abdominal* / chemically induced
  • Aortic Aneurysm, Abdominal* / genetics
  • Aortic Aneurysm, Abdominal* / metabolism
  • Aortic Aneurysm, Abdominal* / pathology
  • Aortic Aneurysm, Abdominal* / prevention & control
  • Aortic Rupture* / chemically induced
  • Aortic Rupture* / genetics
  • Aortic Rupture* / metabolism
  • Aortic Rupture* / pathology
  • Aortic Rupture* / prevention & control
  • Apolipoproteins E
  • Cells, Cultured
  • Disease Models, Animal*
  • Disease Progression*
  • Interferon Type I / genetics
  • Interferon Type I / metabolism
  • Janus Kinases / metabolism
  • Macrophages* / drug effects
  • Macrophages* / metabolism
  • Macrophages* / pathology
  • Male
  • Membrane Proteins* / genetics
  • Membrane Proteins* / metabolism
  • Mice, Inbred C57BL*
  • Mice, Knockout, ApoE*
  • Monocytes* / metabolism
  • Monocytes* / pathology
  • Nucleotidyltransferases / genetics
  • Nucleotidyltransferases / metabolism
  • RNA-Seq
  • Receptor, Interferon alpha-beta* / genetics
  • Receptor, Interferon alpha-beta* / metabolism
  • Signal Transduction*
  • Single-Cell Analysis*

Substances

  • Sting1 protein, mouse
  • Receptor, Interferon alpha-beta
  • Angiotensin II
  • Membrane Proteins
  • Ifnar1 protein, mouse
  • Interferon Type I
  • Nucleotidyltransferases
  • Apoe protein, mouse
  • cGAS protein, mouse
  • Janus Kinases
  • Apolipoproteins E